This study states that the Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), affects approximately 5% of the population, and approximately 30% of affected individuals will die within 30 days of diagnosis. Given the prevalence of VTE and its associated mortality, our study evaluated the success of longitudinal treatment in patients diagnosed with VTE with particular attention to those lost to appropriate follow-up. This is a single-center retrospective study of all consecutive admitted (inpatient [IP]) and emergency department (ED) patients diagnosed with acute VTE by venous duplex ultrasound examination or chest computed tomography from January 2018 to March 2019. Patients with chronic DVT and those diagnosed in the outpatient setting were excluded. Data collected included age, sex, clinical setting at time of diagnosis, discharge anticoagulation choice, discharge disposition, and clinical follow-up. Lost to VTE follow-up (LTFU) was defined as those patients who did not follow up with vascular, cardiovascular, hematology/oncology, pulmonology, or primary care clinic for VTE management at our institution within 3 months after discharge. Patients discharged to hospice were excluded from LTFU analysis. Statistical analysis was performed using Stata 16 software.

Reference link-